// App-Quantinova.ai

4058 : Somatic and Germ-Line Molecular Characteristics Of Prefibrotic Myelofibrosis

Researchers

Presenter

  • Giovanni Barosi

Principal Investigators

  • Elisa Bonetti

  • Paolo Catarsi

  • Gabriela Fois

  • Flavia Biamonte

  • Giada Rotunno

  • Paola Guglielmelli

  • Umberto Magrini

  • Alessandro M. Vannucchi

  • Vittorio Rosti

  • Margherita Massa

  • Rita Campanelli

  • Valentina Poletto

  • Gianluca Viarengo

  • Laura Villani

Medical Centers

  • Center for the Study of Myelofibrosis, Biotechnology Research Area, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

  • Unit of Clinical Immunology, Immunohematology, and Transfusion Service, IRCCS Policlinico San Matteo Foundation, Pavia, Italy

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

  • Medical Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

  • Laboratory of Biotechnology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy

  • University of Florence, Florence, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Extrahepatic portal vein obstruction

  • Myelofibrosis

  • Venous thrombosis

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Enhancer of zeste homolog 2

Drug/Treatment

  • Glucocorticoid

  • EZH2

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim